Community Distribution of Naloxone: A Systematic Review of Economic Evaluations View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-11-11

AUTHORS

Nelda Cherrier, Joanne Kearon, Robin Tetreault, Sophiya Garasia, Emmanuel Guindon

ABSTRACT

BACKGROUND: As a core component of harm-reduction strategies to address the opioid crisis, several countries have instituted publicly funded programs to distribute naloxone for lay administration in the community. The effectiveness in reducing mortality from opioid overdose has been demonstrated in multiple systematic reviews. However, the economic impact of community naloxone distribution programs is not fully understood. OBJECTIVES: Our objective was to conduct a review of economic evaluations of community distribution of naloxone, assessing for quality and applicability to diverse contexts and settings. DATA SOURCES: The search strategy was performed on MEDLINE, Embase, and EconLit databases. STUDY ELIGIBILITY CRITERIA AND INTERVENTIONS: Search criteria were developed based on two themes: (1) papers involving naloxone or narcan and (2) any form of economic evaluation. A focused search of the grey literature was also conducted. Studies exploring the intervention of community distribution of naloxone were selected. STUDY APPRAISAL AND SYNTHESIS METHODS: Data extraction was done using the British Medical Journal guidelines for economic submissions, assigning quality levels based on the impact of the missing or unclear components on the strength of the conclusions. RESULTS: A total of nine articles matched our inclusion criteria: one cost-effectiveness analysis, eight cost-utility analyses, and one cost-benefit analysis. Overall, the quality of the studies was good (six of high quality, two of moderate quality, and one of low quality). All studies concluded that community distribution of naloxone was cost effective, with an incremental cost-utility ratio range of $US111-58,738 (year 2020 values) per quality-adjusted life-year gained. LIMITATIONS: Our search strategy was developed iteratively, rather than following an a priori design. Additionally, our search was limited to English terms. CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS: Based on this review, community distribution of naloxone is a worthwhile investment and should be considered by other countries dealing with the opioid epidemic. More... »

PAGES

1-14

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s41669-021-00309-z

DOI

http://dx.doi.org/10.1007/s41669-021-00309-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1142528336

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34762276


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Applied Economics", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON Canada", 
          "id": "http://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cherrier", 
        "givenName": "Nelda", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON Canada", 
          "id": "http://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kearon", 
        "givenName": "Joanne", 
        "id": "sg:person.010017575021.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010017575021.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON Canada", 
          "id": "http://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tetreault", 
        "givenName": "Robin", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON Canada", 
          "id": "http://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON Canada", 
            "Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garasia", 
        "givenName": "Sophiya", 
        "id": "sg:person.01246337657.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246337657.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON Canada", 
          "id": "http://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON Canada", 
            "Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guindon", 
        "givenName": "Emmanuel", 
        "id": "sg:person.012402437760.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012402437760.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/srep21548", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047590312", 
          "https://doi.org/10.1038/srep21548"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-11-11", 
    "datePublishedReg": "2021-11-11", 
    "description": "BACKGROUND: As a core component of harm-reduction strategies to address the opioid crisis, several countries have instituted publicly funded programs to distribute naloxone for lay administration in the community. The effectiveness in reducing mortality from opioid overdose has been demonstrated in multiple systematic reviews. However, the economic impact of community naloxone distribution programs is not fully understood.\nOBJECTIVES: Our objective was to conduct a review of economic evaluations of community distribution of naloxone, assessing for quality and applicability to diverse contexts and settings.\nDATA SOURCES: The search strategy was performed on MEDLINE, Embase, and EconLit databases.\nSTUDY ELIGIBILITY CRITERIA AND INTERVENTIONS: Search criteria were developed based on two themes: (1) papers involving naloxone or narcan and (2) any form of economic evaluation. A focused search of the grey literature was also conducted. Studies exploring the intervention of community distribution of naloxone were selected.\nSTUDY APPRAISAL AND SYNTHESIS METHODS: Data extraction was done using the British Medical Journal guidelines for economic submissions, assigning quality levels based on the impact of the missing or unclear components on the strength of the conclusions.\nRESULTS: A total of nine articles matched our inclusion criteria: one cost-effectiveness analysis, eight cost-utility analyses, and one cost-benefit analysis. Overall, the quality of the studies was good (six of high quality, two of moderate quality, and one of low quality). All studies concluded that community distribution of naloxone was cost effective, with an incremental cost-utility ratio range of $US111-58,738 (year 2020 values) per quality-adjusted life-year gained.\nLIMITATIONS: Our search strategy was developed iteratively, rather than following an a priori design. Additionally, our search was limited to English terms.\nCONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS: Based on this review, community distribution of naloxone is a worthwhile investment and should be considered by other countries dealing with the opioid epidemic.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s41669-021-00309-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1284515", 
        "issn": [
          "2509-4262", 
          "2509-4254"
        ], 
        "name": "PharmacoEconomics - Open", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "economic evaluation", 
      "British Medical Journal guidelines", 
      "cost-utility analysis", 
      "cost-effectiveness analysis", 
      "cost-benefit analysis", 
      "economics submissions", 
      "economic impact", 
      "EconLit databases", 
      "worthwhile investment", 
      "distribution program", 
      "quality level", 
      "countries", 
      "systematic review", 
      "multiple systematic reviews", 
      "study eligibility criteria", 
      "key findings", 
      "naloxone distribution programs", 
      "journal guidelines", 
      "harm reduction strategies", 
      "investment", 
      "crisis", 
      "opioid overdose", 
      "STUDY APPRAISAL", 
      "inclusion criteria", 
      "opioid epidemic", 
      "naloxone", 
      "impact", 
      "eligibility criteria", 
      "opioid crisis", 
      "data extraction", 
      "search strategy", 
      "grey literature", 
      "lay administration", 
      "search criteria", 
      "strategies", 
      "intervention", 
      "unclear components", 
      "implications", 
      "review", 
      "conclusion", 
      "EMBASE", 
      "analysis", 
      "mortality", 
      "overdose", 
      "MEDLINE", 
      "literature", 
      "appraisal", 
      "article", 
      "program", 
      "administration", 
      "evaluation", 
      "criteria", 
      "study", 
      "distribution", 
      "quality", 
      "context", 
      "total", 
      "epidemic", 
      "objective", 
      "focused search", 
      "terms", 
      "guidelines", 
      "findings", 
      "setting", 
      "search", 
      "English terms", 
      "levels", 
      "database", 
      "effectiveness", 
      "submission", 
      "core component", 
      "components", 
      "community", 
      "form", 
      "themes", 
      "applicability", 
      "method", 
      "design", 
      "extraction", 
      "range", 
      "strength", 
      "community distribution", 
      "ratio range", 
      "paper", 
      "synthesis method", 
      "community naloxone distribution programs", 
      "Medical Journal guidelines", 
      "incremental cost-utility ratio range", 
      "cost-utility ratio range", 
      "US111"
    ], 
    "name": "Community Distribution of Naloxone: A Systematic Review of Economic Evaluations", 
    "pagination": "1-14", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1142528336"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s41669-021-00309-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34762276"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s41669-021-00309-z", 
      "https://app.dimensions.ai/details/publication/pub.1142528336"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T19:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_903.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s41669-021-00309-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00309-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00309-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00309-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00309-z'


 

This table displays all metadata directly associated to this object as RDF triples.

186 TRIPLES      22 PREDICATES      116 URIs      105 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s41669-021-00309-z schema:about anzsrc-for:11
2 anzsrc-for:1117
3 anzsrc-for:14
4 anzsrc-for:1402
5 schema:author N789b7203c63e47c69cfe18461b68449d
6 schema:citation sg:pub.10.1038/srep21548
7 schema:datePublished 2021-11-11
8 schema:datePublishedReg 2021-11-11
9 schema:description BACKGROUND: As a core component of harm-reduction strategies to address the opioid crisis, several countries have instituted publicly funded programs to distribute naloxone for lay administration in the community. The effectiveness in reducing mortality from opioid overdose has been demonstrated in multiple systematic reviews. However, the economic impact of community naloxone distribution programs is not fully understood. OBJECTIVES: Our objective was to conduct a review of economic evaluations of community distribution of naloxone, assessing for quality and applicability to diverse contexts and settings. DATA SOURCES: The search strategy was performed on MEDLINE, Embase, and EconLit databases. STUDY ELIGIBILITY CRITERIA AND INTERVENTIONS: Search criteria were developed based on two themes: (1) papers involving naloxone or narcan and (2) any form of economic evaluation. A focused search of the grey literature was also conducted. Studies exploring the intervention of community distribution of naloxone were selected. STUDY APPRAISAL AND SYNTHESIS METHODS: Data extraction was done using the British Medical Journal guidelines for economic submissions, assigning quality levels based on the impact of the missing or unclear components on the strength of the conclusions. RESULTS: A total of nine articles matched our inclusion criteria: one cost-effectiveness analysis, eight cost-utility analyses, and one cost-benefit analysis. Overall, the quality of the studies was good (six of high quality, two of moderate quality, and one of low quality). All studies concluded that community distribution of naloxone was cost effective, with an incremental cost-utility ratio range of $US111-58,738 (year 2020 values) per quality-adjusted life-year gained. LIMITATIONS: Our search strategy was developed iteratively, rather than following an a priori design. Additionally, our search was limited to English terms. CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS: Based on this review, community distribution of naloxone is a worthwhile investment and should be considered by other countries dealing with the opioid epidemic.
10 schema:genre article
11 schema:inLanguage en
12 schema:isAccessibleForFree true
13 schema:isPartOf sg:journal.1284515
14 schema:keywords British Medical Journal guidelines
15 EMBASE
16 EconLit databases
17 English terms
18 MEDLINE
19 Medical Journal guidelines
20 STUDY APPRAISAL
21 US111
22 administration
23 analysis
24 applicability
25 appraisal
26 article
27 community
28 community distribution
29 community naloxone distribution programs
30 components
31 conclusion
32 context
33 core component
34 cost-benefit analysis
35 cost-effectiveness analysis
36 cost-utility analysis
37 cost-utility ratio range
38 countries
39 crisis
40 criteria
41 data extraction
42 database
43 design
44 distribution
45 distribution program
46 economic evaluation
47 economic impact
48 economics submissions
49 effectiveness
50 eligibility criteria
51 epidemic
52 evaluation
53 extraction
54 findings
55 focused search
56 form
57 grey literature
58 guidelines
59 harm reduction strategies
60 impact
61 implications
62 inclusion criteria
63 incremental cost-utility ratio range
64 intervention
65 investment
66 journal guidelines
67 key findings
68 lay administration
69 levels
70 literature
71 method
72 mortality
73 multiple systematic reviews
74 naloxone
75 naloxone distribution programs
76 objective
77 opioid crisis
78 opioid epidemic
79 opioid overdose
80 overdose
81 paper
82 program
83 quality
84 quality level
85 range
86 ratio range
87 review
88 search
89 search criteria
90 search strategy
91 setting
92 strategies
93 strength
94 study
95 study eligibility criteria
96 submission
97 synthesis method
98 systematic review
99 terms
100 themes
101 total
102 unclear components
103 worthwhile investment
104 schema:name Community Distribution of Naloxone: A Systematic Review of Economic Evaluations
105 schema:pagination 1-14
106 schema:productId N77e586f3f3e347ed85e8d499341c151a
107 N851f2f9764e948358d62ecfb1db9217a
108 Nc83261e2cefd44ae998f227651e23dbd
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1142528336
110 https://doi.org/10.1007/s41669-021-00309-z
111 schema:sdDatePublished 2022-01-01T19:01
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher N6a0b2e00c48b4c56a6f123ee487ee271
114 schema:url https://doi.org/10.1007/s41669-021-00309-z
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N046566ab464c40d08608095023c4dd7c schema:affiliation grid-institutes:grid.25073.33
119 schema:familyName Tetreault
120 schema:givenName Robin
121 rdf:type schema:Person
122 N460b1e7a70ca485e91c51a5c3539f425 rdf:first sg:person.012402437760.30
123 rdf:rest rdf:nil
124 N4ba3309c879f4114ae4a54e4e0bd88a5 rdf:first N046566ab464c40d08608095023c4dd7c
125 rdf:rest N5403e2dd2103494ba4e8fbf86c0d981f
126 N5403e2dd2103494ba4e8fbf86c0d981f rdf:first sg:person.01246337657.62
127 rdf:rest N460b1e7a70ca485e91c51a5c3539f425
128 N6a0b2e00c48b4c56a6f123ee487ee271 schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 N77e586f3f3e347ed85e8d499341c151a schema:name dimensions_id
131 schema:value pub.1142528336
132 rdf:type schema:PropertyValue
133 N789b7203c63e47c69cfe18461b68449d rdf:first Nf1512eb6b1884c2c84dfa1b46002c346
134 rdf:rest Nc8e2e806fe9c453e91f4c56d690e1cf5
135 N851f2f9764e948358d62ecfb1db9217a schema:name pubmed_id
136 schema:value 34762276
137 rdf:type schema:PropertyValue
138 Nc83261e2cefd44ae998f227651e23dbd schema:name doi
139 schema:value 10.1007/s41669-021-00309-z
140 rdf:type schema:PropertyValue
141 Nc8e2e806fe9c453e91f4c56d690e1cf5 rdf:first sg:person.010017575021.33
142 rdf:rest N4ba3309c879f4114ae4a54e4e0bd88a5
143 Nf1512eb6b1884c2c84dfa1b46002c346 schema:affiliation grid-institutes:grid.25073.33
144 schema:familyName Cherrier
145 schema:givenName Nelda
146 rdf:type schema:Person
147 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
148 schema:name Medical and Health Sciences
149 rdf:type schema:DefinedTerm
150 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
151 schema:name Public Health and Health Services
152 rdf:type schema:DefinedTerm
153 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
154 schema:name Economics
155 rdf:type schema:DefinedTerm
156 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
157 schema:name Applied Economics
158 rdf:type schema:DefinedTerm
159 sg:journal.1284515 schema:issn 2509-4254
160 2509-4262
161 schema:name PharmacoEconomics - Open
162 schema:publisher Springer Nature
163 rdf:type schema:Periodical
164 sg:person.010017575021.33 schema:affiliation grid-institutes:grid.25073.33
165 schema:familyName Kearon
166 schema:givenName Joanne
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010017575021.33
168 rdf:type schema:Person
169 sg:person.012402437760.30 schema:affiliation grid-institutes:grid.25073.33
170 schema:familyName Guindon
171 schema:givenName Emmanuel
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012402437760.30
173 rdf:type schema:Person
174 sg:person.01246337657.62 schema:affiliation grid-institutes:grid.25073.33
175 schema:familyName Garasia
176 schema:givenName Sophiya
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246337657.62
178 rdf:type schema:Person
179 sg:pub.10.1038/srep21548 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047590312
180 https://doi.org/10.1038/srep21548
181 rdf:type schema:CreativeWork
182 grid-institutes:grid.25073.33 schema:alternateName Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON Canada
183 Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON Canada
184 schema:name Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON Canada
185 Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON Canada
186 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...